Early Phase Clinical Trials
At Collaborative Neuroscience Network, we know that successful early phase clinical research programs are essential to establishing your product quickly and safely. To provide the integrity, quality, and flexibility you need – we have an exceptional array of immediate resources to support both healthy normal volunteers (HNV) and patient populations in early clinical trials.
We are able to deliver results efficiently, for drugs that span multiple therapeutic areas, while always ensuring the safety of our participants:
- Bioavailability and Bioequivalence
- First-in-Human – Single and multiple ascending doses in healthy participants or patients
- Interaction – Drug-drug, food effect, fed and fasted
- Pharmacokinetic (PK)
- Pharmacodynamics (PD)
- Thorough QT
Want to Learn More?
Whether you are a large pharmaceutical company, biopharmaceutical firm, or a maker of generic drugs, we have the expertise to expedite your decision, saving you time and money. Contact us today to learn how CNS can make your early phase research program a success.
“Dr. [Omid] Omidvar, [Collaborative Neuroscience Network], your pace of screening and randomizing patients over the last couple months is impressive. We need to clone your site. Thank you.”